"With a team of over 200 researchers, Sanford Research is comprised of eight groups that bridge bench, translational and clinical research including: Cancer Biology and Immunotherapies, Pediatrics and Rare Diseases, Diabetes, Cellular Therapies and Stem Cell Biology, Enabling Technology, Environmental Influences on Health and Disease, Genetics and Genomics, and Population Health."

During the past decade, Sanford Research conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 28 clinical trials were completed, i.e. on average, 93.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 20 clinical trials were completed. i.e. 666.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sanford Research" #1 sponsor was "Bristol-Myers Squibb" with 4 trials, followed by "Pfizer" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 3 trials sponsored and "Abbott Medical Devices" with 3 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sanford Research" #1 collaborator was "Immune Tolerance Network (ITN)" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "California Institute for Regenerative Medicine (CIRM)" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Sanford Research" are "Cystic Fibrosis" (3 trials), "Heart Failure" (3 trials), "Breast Cancer" (2 trials), "Breast Neoplasms" (2 trials) and "Cancer" (2 trials). Many other conditions were trialed in "Sanford Research" in a lesser frequency.

Most popular intervention types in "Sanford Research" are "Drug" (29 trials), "Biological" (9 trials), "Other" (7 trials), "Device" (6 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Bevacizumab" (3 trials), "IVA" (3 trials), "Nivolumab" (3 trials) and "Abemaciclib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sanford Research" are 42 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Sanford Research". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Sanford Research, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Sanford Research, 8 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".